期刊文献+

丙酮酸脱氢酶E1α亚单位缺陷导致Leigh综合征 被引量:18

Leigh syndrome due to pyruvate dehydrogenase E1 alpha subunit gene mutation:A complicated and difficult case study
下载PDF
导出
摘要 Leigh综合征是由于线粒体呼吸链能量代谢障碍所导致的遗传性疾病,丙酮酸脱氢酶E1浕亚单位(pyruvate dehydrogenase complex E1 alpha subunit,PDHA1)缺陷是导致Leigh综合征的常见原因之一。该研究通过PDHA1基因分析首次确诊了1例中国患者。该患儿1岁后运动发育落后,无力,肌张力低下,肌腱反射消失,发热、感冒时间歇性加重,智力发育正常。肌电图检查、腓肠肌病理活检结果提示神经性损害。3岁时脑MRI扫描未见异常,5岁时脑MRI呈现双侧苍白球对称性损害,符合Leigh综合征表现。经基因分析证实患者及其母亲PDHA1基因外显子3存在C214T突变,导致丙酮酸脱氢酶复合物活性下降。经过维生素B1、辅酶Q10、左旋肉碱及低碳水化合物饮食治疗后,患儿运动能力显著改善,现在8岁,正常就学。PDHA1缺陷为X连锁遗传性疾病,表型复杂,临床诊断困难,该患儿以无力为主要表现,经基因诊断确诊。 Leigh syndrome is a genetically heterogeneous disease caused by defects in enzymes involved in aerobic energy metabolism and the Krebs' cycle. Deficiency of pyruvate dehydrogenase complex E1 alpha subunit (PDHA1) is the common cause of Leigh syndrome. In this study, one Chinese case of PDHA1 deficiency was reported. The patient was a boy with normal mental development, retarded motor development, general weakness, hypotonia and areflexia. Muscle histopathological findings suggested axonal peripheral neuropathy. Brain magnetic resonance imaging at 5 years of age revealed bilateral putamina lesions and periventricular white matter demyelination, supporting the diagnosis of Leigh syndrome. A C214T mutation in exon 3 of the PDHA1 gene was detected. After the treatment of thiamin, coenzyme Q10, L- carnitine and carbohydrates-restricted diet, his movement ability improved significantly. At present, the patient is 8 years old and has normal school life. PDHA1 deficiency is an X-linked inherited metabolic disease, which shares various clinical manifestations and leads to difficult diagnosis. This patient predominately presented with progressive weakness and was diagnosed by gene analysis.
出处 《中国当代儿科杂志》 CAS CSCD 2007年第3期216-219,共4页 Chinese Journal of Contemporary Pediatrics
基金 北京大学人类疾病基因研究中心科研基金(2001-02) 国家自然科学基金面上项目(30471832) 卫生部临床学科重点项目(2001-0912)资助。
关键词 LEIGH综合征 丙酮酸脱氢酶Ela亚单位(PDHA1) 无力 基因突变 X连锁遗传性疾病 Leigh syndrome Pyruvate dehydrogenase complex E1α subunit (PDHA1) Weakness Gene mutation
  • 相关文献

参考文献26

  • 1Munnich A,Rσtig A,Cormier-Daire V,Rustin P.Clinical presentation of respiratory chain deficiency[M].//The Metabolic & Molecular Bases of Inherited Disease.Scriver CR,Beaudet AL,Sly WS,et al.8th ed.New York:McGraw-Hill,2001,2261-2274.
  • 2张尧,杨艳玲,秦炯.丙酮酸脱氢酶复合物缺陷与疾病[J].临床儿科杂志,2006,24(12):956-958. 被引量:11
  • 3Smeitink J,van den Heuvel L,DiMauro S.The genetics and pathology of oxidative phosphorylation[J].Nat Rev Genet,2001,2(5):342-352.
  • 4Brown RM,Dahl HH,Brown GK.X-chromosome localization of the functional gene for the E1 alpha subunit of the human pyruvate dehydrogenase complex[J].Genomics,1989,4(2):174-181.
  • 5Lissens W,De Meirleir L,Seneca S,Lebaers 1,Brown GK,Brown RM.et a1.Mutations in the X-linked pyruvate dehydrogenase(E1) α subunit gene(PDHAl) in patients with a pyruvate dehydrogenase complex deficiency[J].Hum Mutat,2000,15(3):209-219.
  • 6Szabo P,Sheu KF,Robinson RM,Grzeschik KH,Blass JP.The gene for the alpha polypeptide of pyruvate dehydrogenase is X1inked in humans[J].Am J Hum Genet,1990,46(5):874-878.
  • 7Koike K,Ohta S,Urata Y,Kagawa Y,Koike M.Cloning and sequencing of cDNAs encoding alpha and beta subunits of human pyruvate dehydrogenase[J].Proc Natl Acad Sci USA,1988,85(1):41-45.
  • 8Johnson MT,Mahmood S,Hyatt SL,Yang HS,Soloway PD,Hanson RW,et a1.Inactivation of the murine pyruvate dehydrogenase(PDHAl)gene and its effect on early embryonic development[J].Mol Genet Metab,2001,74(3):293-302.
  • 9Cameron JM,Levandovskiy V,Mackay N,Tein I,Robinson BH.Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1 alpha subunit[J].Am J Med Genet A,2004,131(1):59-66.
  • 10Ito M,Huq AH,Naito E,Saijo T,Takeda E,Kuroda Y.Mutations in the gene for the E1 beta subunit:a novel cause of pyruvate dehydrogenase deficiency[J].Hum Genet,2004,115(2):123-127.

二级参考文献75

  • 1孙芳,戚豫,王丽,杨艳玲.Leigh综合征的临床和分子遗传学研究进展[J].中国当代儿科杂志,2005,7(2):186-189. 被引量:11
  • 2闻之梅 陈君石.现代营养学[M].北京:人民卫生出版社,1998.310-313.
  • 3Rahman S, Blok RB, Dahl HH, et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol, 1996, 39: 343-351.
  • 4Head RA, Brown RM, Brown GK. Diagnostic difficulties with common SURF1 mutations in patients with cytochrome oxidase-deficient Leigh syndrome. J Inherit Metab Dis, 2004, 27: 57-65.
  • 5Zhu Z, Yao J, Johns T, et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet, 1998, 20: 337-343.
  • 6Tiranti V, Hoertnagel K, Carrozzo R, et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet, 1998, 63: 1609-1621.
  • 7Miller SA, Dykes DD, Poleskey HF. A simple salting out procedure for extracting DNA from human nucleated cell. Nucleic Acids Res, 1988, 16: 1215.
  • 8Smeitink J, van den Heuvel L, DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet, 2001, 2: 342-352.
  • 9Poyau A, Buchet K, Godinot C. Sequence conservation from human to prokaryotes of Surf1, a protein involved in cytochrome c oxidase assembly, deficient in Leigh syndrome. FEBS Lett, 1999, 462: 416-420.
  • 10Poyau A, Buchet K, Bouzidi MF, et al. Missense mutations in SURF1 associated with deficient cytochrome c oxidase assembly in Leigh syndrome patients. Hum Genet, 2000,106: 194-205.

共引文献43

同被引文献238

引证文献18

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部